We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
451
TJX Companies
TJX
$173B
$29 ﹤0.01%
560
WELL icon
452
Welltower
WELL
$176B
$29 ﹤0.01%
559
+264
+89% +$13K
AEE icon
453
Ameren
AEE
$31.1B
$28 ﹤0.01%
400
DKNG icon
454
DraftKings
DKNG
$12.1B
$28 ﹤0.01%
850
+200
+31% +$5.53K
EPP icon
455
iShares MSCI Pacific ex Japan ETF
EPP
$2.19B
$28 ﹤0.01%
+705
New +$26.4K
IGIB icon
456
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$28 ﹤0.01%
+477
New +$27.8K
MRCC
457
DELISTED
Monroe Capital Corp
MRCC
$28 ﹤0.01%
4,000
DHT icon
458
DHT Holdings
DHT
$2.96B
$27 ﹤0.01%
+5,316
New +$33.9K
SILV
459
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$27 ﹤0.01%
2,960
+1,000
+51% +$7.51K
VAR
460
DELISTED
Varian Medical Systems, Inc.
VAR
$27 ﹤0.01%
220
JCAP
461
DELISTED
Jernigan Capital, Inc.
JCAP
$27 ﹤0.01%
2,000
BZH icon
462
Beazer Homes USA
BZH
$911M
$26 ﹤0.01%
+2,604
New +$20.8K
CCAP icon
463
Crescent Capital BDC
CCAP
$402M
$26 ﹤0.01%
2,020
EDIT icon
464
Editas Medicine
EDIT
$404M
$26 ﹤0.01%
+910
New +$23.8K
EXC icon
465
Exelon
EXC
$48.4B
$26 ﹤0.01%
994
IYW icon
466
iShares US Technology ETF
IYW
$23.3B
$26 ﹤0.01%
+400
New +$24.1K
MSB
467
Mesabi Trust
MSB
$292M
$26 ﹤0.01%
+1,500
New +$23.4K
NTR icon
468
Nutrien
NTR
$32.2B
$26 ﹤0.01%
800
-1,800
-69% -$62.6K
DOC
469
DELISTED
PHYSICIANS REALTY TRUST
DOC
$26 ﹤0.01%
1,485
+100
+7% +$1.63K
CIO
470
DELISTED
City Office REIT
CIO
$25 ﹤0.01%
2,500
DELL icon
471
Dell
DELL
$273B
$25 ﹤0.01%
880
-789
-47% -$17.7K
FRO icon
472
Frontline
FRO
$8.68B
$25 ﹤0.01%
+3,572
New +$30.3K
HACK icon
473
Amplify Cybersecurity ETF
HACK
$2.65B
$25 ﹤0.01%
+565
New +$23.4K
PKG icon
474
Packaging Corp of America
PKG
$22.4B
$25 ﹤0.01%
252
RCL icon
475
Royal Caribbean
RCL
$78.6B
$25 ﹤0.01%
500
+400
+400% +$18.1K

Similar funds

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.